Compare Ginkgo Bioworks Holdings Inc (DNA) vs NetEase Inc (NTES) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs NetEase Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while NetEase Inc trades at $123.19 (market cap $82.75B). The key difference: NetEase Inc is far larger — about 163.6× Ginkgo Bioworks Holdings Inc's market cap, and NetEase Inc pays a 2.36% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | NTES | |
|---|---|---|
Market Cap | $505.73M | $82.75B |
Sector | Health | Media |
52-Week High | $16.14 | $159.34 |
52-Week Low | $5.48 | $109.26 |
Enterprise Value | $607.68M | $59.05B |
Dividend Yield | — | 2.36% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About NetEase Inc
NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
Read more on NTES →
